Abuse and resilience in relation to haart medication adherence and HIV viral load among women with HIV in the United States

AIDS Patient Care and STDs

Volumn 28, Issue 3, 2014, Pages 136-143

  Dale, Sannisha ^a   Cohen, Mardge ^b   Weber, Kathleen ^b   Cruise, Ruth ^a   Kelso, Gwendolyn ^a   Brody, Leslie ^a  

^a BOSTON UNIVERSITY   (United States)

^b Department of Ambulatory and Community Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; CONVENIENCE SAMPLE; COPING BEHAVIOR; DEPRESSION; DOMESTIC VIOLENCE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MEDICATION COMPLIANCE; MIDDLE AGED; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PHYSICAL ABUSE; RACE; RATING SCALE; SEXUAL ABUSE; STRUCTURED INTERVIEW; SUBSTANCE USE; UNITED STATES; VIRUS LOAD;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MEDICATION ADHERENCE; MIDDLE AGED; QUESTIONNAIRES; RESILIENCE, PSYCHOLOGICAL; SEX OFFENSES; SPOUSE ABUSE; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; UNITED STATES; VIRAL LOAD;

EID: 84896764164     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2013.0329     Document Type: Article

References (70)

1. Centers for Disease Control Prevention. HIV Prevalence Estimates-United States, 2006. MMWR 2008:57:1073-1076.
2. Leserman J, Pence BW, Whetten K, et al. Relation of lifetime trauma and depressive symptoms to mortality in HIV. Am J Psychiatr 2007;164:1707-1713. (Pubitemid 350205348)
3. Machtinger EL, Haberer JE, Wilson TC, Weiss DS. Recent trauma is associated with antiretroviral failure and HIV transmission risk behavior among HIV-positive women and female-identified transgenders. AIDS Behav 2012;16: 2160-2170.
4. Connor KM, Davidson JRT. Development of a new resilience scale: The Connor-Davidson Resilience Scale (CDRISC). Depress Anxiety 2003;18:76-82. (Pubitemid 37175584)
5. Farber EW, Schwartz JA, Schaper PE, Moonen DJ, McDaniel JS. Resilience factors associated with adaptation to HIV disease. Psychosomatics 2000;41:140-146. (Pubitemid 30159893)
6. Wingo AP, Wrenn G, Pelletier T, Gutman AR, Bradley B, Ressler KJ. Moderating effects of resilience on depression in individuals with a history of childhood abuse or trauma exposure. J Affect Disord 2010;126:411-414.
7. Yu XN, Lau JT, Mak WW, Cheng YM, Lv YH, Zhang JX. Risk and protective factors in association with mental health problems among people living with HIV who were former plasma/blood donors in rural China. AIDS Care 2009;21:645-654.
8. CohenM, Deamant C, Barkan S, et al. Domestic violence and childhood sexual abuse in HIV-infected women and women at risk for HIV. Am J Public Health 2000;90:560-565. (Pubitemid 30167416)
9. Machtinger EL, Wilson TC, Haberer JE, Weiss DS. Psychological trauma and PTSD in HIV-positive women: A meta-analysis. AIDS Behav 2012;16:2091-2100.
10. Arriola KR, Louden T, Doldren MA, Fortenberry RM. A meta-analysis of the relationship of child sexual abuse to HIV risk behavior among women. Child Abuse Negl 2005; 29:725-746. (Pubitemid 40984709)
11. Cohen MH, Cook JA, Grey D, et al. Medically eligible women who do not use HAART: The importance of abuse, drug use, and race. Am J Public Health 2004;94:1147-1151. (Pubitemid 38857315)
12. Keuroghlian AS, Kamen CS, Neri E, Lee S, Liu R, Gore-Felton C. Trauma, dissociation, and antiretroviral adherence among persons living with HIV/AIDS. J Psychiatr Res 2011;45:942-948.
13. Meade CS, Hansen NB, Kochman A, Sikkema KJ. Utilization of medical treatments and adherence to antiretroviral therapy among HIV-positive adults with histories of childhood sexual abuse. AIDS Patient Care STDS 2009;23:259-266.
14. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30. (Pubitemid 30432540)
15. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr 2004;35:261-268. (Pubitemid 38280651)
16. Garcia de Olalla P, Knobel H, Carmona A, Guelar A, Lopez-Colomes JL, Cayla JA. Impact of adherence and highly active antiretroviral therapy on survival in HIVinfected patients. J Acquir Immune Defic Syndr 2002;30: 105-110. (Pubitemid 34506694)
17. Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis 2006;43:939-941. (Pubitemid 44435526)
18. Shuter J, Sarlo JA, Kanmaz TJ, Rode RA, Zingman BS. HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. J Acquir Immune Defic Syndr 2007;45:4-8. (Pubitemid 46684437)
19. Golin CE, Liu H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med 2002;17:756-765. (Pubitemid 35286241)
20. Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis 2002;34:1115-1121. (Pubitemid 34289685)
21. Howard AA, Arnsten JH, Lo Y, et al. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS 2002;16:2175-2182. (Pubitemid 35387272)
22. Richman DD, Morton SC, Wrin T, et al. The prevalence of antiretroviral drug resistance in the United States. AIDS 2004;18:1393-1401. (Pubitemid 38925131)
23. Lucas GM. Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: A tangled web is woven. J Antimicrob Chemother 2005;55:413-416. (Pubitemid 40542576)
24. Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 1998;279:1977-1983. (Pubitemid 28298277)
25. Vyavaharkar M, Moneyham L, Tavakoli A, et al. Social support, coping, and medication adherence among HIVpositive women with depression living in rural areas of the southeastern United States. AIDS Patient Care STDs 2007; 21:667-680. (Pubitemid 47525390)
26. Kalokhe AS, Paranjape A, Bell CE, et al. Intimate partner violence among HIV-infected crack cocaine users. AIDS Patient Care STDS 2012;26:234-240.
27. Tedaldi EM, van den Berg-Wolf M, Richardson J, et al. Sadness in the SUN: Using computerized screening to analyze correlates of depression and adherence in HIVinfected adults in the United States. AIDS Patient Care STDS 2012;26:718-729.
28. Toth M, Messer LC, Quinlivan EB. Barriers to HIV care for women of color living in the Southeastern US are associated with physical symptoms, social environment, and selfdetermination. AIDS Patient Care STDS 2013;27:613-620.
29. Schafer KR, Brant J, Gupta S, et al. Intimate partner violence: A predictor of worse HIV outcomes and engagement in care. AIDS Patient Care STDS 2012;26:356-365.
30. Tjaden P, Thoennes N. Extent, nature, and consequences of intimate partner violence: Findings from the National Violence Against Women Survey. Washington, DC: National Institute of Justice and the Centers for Disease Control and Prevention, July 2000.
31. Centers for Disease Control and Prevention. HIV infection among heterosexuals at increased risk-United States, 2010. Morbidity Mortality Weekly Rep 2013;62:183-188.
32. Demarco R, Lynch MM, Board R. Mothers who silence themselves: A concept with clinical implications for women living with HIV/AIDS and their children. J Pediatr Nurs 2002;17:89-95. (Pubitemid 40433710)
33. Whetten K, Reif S, Whetten R, Murphy-McMillan LK. Trauma, mental health, distrust, and stigma among HIVpositive persons: Implications for effective care. Psychosom Med 2008;70:531-538.
34. Kelso GA, Cohen MH, Weber KM, Dale SK, Cruise RC, Brody LR. Critical consciousness, racial and gender discrimination, and HIV disease markers in African American women with HIV. AIDS Behav 2013 Sept 28 [Epub ahead of print] DOI: 10.1007/s10461-013-0621-y.
35. Kobasa SC. Stressful life events, personality, and health: An inquiry into hardiness. J Pers Soc Psychol 1979;37:1-11.
36. Rutter M. Resilience in the face of adversity: Protective factors and resistance to psychiatric disorder. Br J Psychiatr 1985;147:598-611. (Pubitemid 16175701)
37. Lyons J. Strategies for assessing the potential for positive adjustment following trauma. J Trauma Stress 1991/01/01 1991;4:93-111.
38. Werner EE. Risk, resilience, and recovery: Perspectives from the Kauai Longitudinal Study. Dev Psychopathol 1993;5:503-515.
39. Olsson CA, Bond L, Burns JM, Vella-Brodrick DA, Sawyer SM. Adolescent resilience: A concept analysis. J Adolesc 2003;26:1-11. (Pubitemid 36503753)
40. Jacelon CS. The trait and process of resilience. J Adv Nurs 1997;25:123-129. (Pubitemid 127454779)
41. Bonanno GA. Uses and abuses of the resilience construct: Loss, trauma, and health-related adversities. Soc Sci Med 2012;74:753-756.
42. Bonanno GA, Galea S, Bucciarelli A, Vlahov D. Psychological resilience after disaster: New York City in the aftermath of the September 11th terrorist attack. Psychol Sci 2006;17:181-186. (Pubitemid 43344723)
43. Davidson J, Stein DJ, Rothbaum BO, Pedersen R, Szumski A, Baldwin DS. Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo. J Psychopharmacol 2012;26:778-783.
44. Campbell-Sills L, Stein MB. Psychometric analysis and refinement of the connor-davidson resilience scale (CD-RISC): Validation of a 10-item measure of resilience. J Trauma Stress 2007;20:1019-1028.
45. Min JA, Lee NB, Lee CU, Lee C, Chae JH. Low trait anxiety, high resilience, and their interaction as possible predictors for treatment response in patients with depression. J Affect Disord 2012;137:61-69.
46. Sexton MB, Byrd MR, von Kluge S. Measuring resilience in women experiencing infertility using the CD-RISC: Examining infertility-related stress, general distress, and coping styles. J Psychiatr Res 2010;44:236-241.
47. Wang L, Shi Z, Zhang Y, Zhang Z. Psychometric properties of the 10-item Connor-Davidson Resilience Scale in Chinese earthquake victims. Psychiatry Clin Neurosci 2010;64:499-504.
48. Fadardi JS, Azad H, Nemati A. The relationship between resilience, motivational structure, and substance use. Procedia Soc Behav Sci 2010;5:1956-1960.
49. Pietrzak RH, Johnson DC, Goldstein MB, Malley JC, Southwick SM. Psychological resilience and postdeployment social support protect against traumatic stress and depressive symptoms in soldiers returning from Operations Enduring Freedom and Iraqi Freedom. Depress Anxiety 2009;26:745-751.
50. Yi JP, Vitaliano PP, Smith RE, Yi JC, Weinger K. The role of resilience on psychological adjustment and physical health in patients with diabetes. Br J Health Psychol 2008;13:311-325. (Pubitemid 351744315)
51. Ickovics JR, Milan S, Boland R, et al. Psychological resources protect health: 5-year survival and immune function among HIV-infected women from four US cities. AIDS 2006;20:1851-1860. (Pubitemid 44358903)
52. Ironson G, Hayward H. Do positive psychosocial factors predict disease progression in HIV-1? A review of the evidence. Psychosom Med 2008;70:546-554.
53. Psychd ST, Troop M, Burgess AP, et al. The relationship of psychological variables and disease progression among longterm HIV-infected men. Int J STD AIDS 2000;11:734-742.
54. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998;9:117-125. (Pubitemid 28157608)
55. Bacon MC, von Wyl V, Alden C, et al. The Women's Interagency HIV Study: An observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol 2005;12:1013-1019. (Pubitemid 41324530)
56. Lazo M, Gange SJ, Wilson TE, et al. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: Longitudinal study of men and women. Clin Infect Dis 2007;45:1377-1385. (Pubitemid 351411918)
57. Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: A meta-analysis. J Acquir Immune Defic Syndr 2005;38:445-448. (Pubitemid 40381555)
58. Wilson TE, Barron Y, Cohen M, et al. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis 2002;34:529-534. (Pubitemid 34112276)
59. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and an expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recommend Rep 1992; 41:1-19.
60. Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 2002;17:377-381. (Pubitemid 34626108)
61. Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
62. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study. JAMA 2001;285: 1466-1474. (Pubitemid 32221895)
63. Cook JA, Cohen MH, Burke J, et al. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr 2002;30:401-409. (Pubitemid 34857314)
64. Gidron Y, Gilutz H, Berger R, Huleihel M. Molecular and cellular interface between behavior and acute coronary syndromes. Cardiovasc Res 2002;56:15-21. (Pubitemid 35247798)
65. Maier SF, Watkins LR, Fleshner M. Psychoneuroimmunology. The interface between behavior, brain, and immunity. Am Psychol 1994;49:1004-1017. (Pubitemid 24976677)
66. Scali J, Gandubert C, Ritchie K, Soulier M, Ancelin ML, Chaudieu I. Measuring resilience in adult women using the 10-items Connor-Davidson Resilience Scale (CD-RISC). Role of trauma exposure and anxiety disorders. PLoS One 2012;7:e39879.
67. Steinhardt M, Dolbier C. Evaluation of a resilience intervention to enhance coping strategies and protective factors and decrease symptomatology. J Am Coll Health 2008;56:445-453.
68. Steinhardt MA, Mamerow MM, Brown SA, Jolly CA. A resilience intervention in African American adults with type 2 diabetes: A pilot study of efficacy. Diabetes Educ 2009;35:274-284.
69. Barclay TR, Hinkin CH, Castellon SA, et al. Age-associated predictors of medication adherence in HIV-positive adults: Health beliefs, self-efficacy, and neurocognitive status. Health Psychol 2007;26:40-49. (Pubitemid 46072023)
70. Brown JL, Littlewood RA, Vanable PA. Social-cognitive correlates of antiretroviral therapy adherence among HIVinfected individuals receiving infectious disease care in a medium-sized northeastern US city. AIDS Care 2013;25: 1149-1158.